HDAC9 and cancer: It was shown that only the pan-HDAC inhibitor SAHA and the HDAC3-specific inhibitor RGFP966 markedly increased PD-L1 expression in all the parental cancer cells in our study (Additional file 1: Figure S4), suggesting the important role of HDAC3.